Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of MEF2C mRNA | decreases expression | 18648102
|
C090942 |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Phenylephrine results in increased expression of MEF2C mRNA] | decreases reaction|increases expression | 10737771
|
D013196 |
Dihydrotestosterone |
Dihydrotestosterone results in increased expression of MEF2C mRNA | increases expression | 18007998
|
D000638 |
Amiodarone |
Amiodarone results in increased expression of MEF2C mRNA | increases expression | 19774075
|
D001151 |
Arsenic |
Arsenic affects the expression of MEF2C mRNA | affects expression | 18414638
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of MEF2C mRNA | decreases expression | 20064835
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of MEF2C mRNA | increases expression | 18007998
|
C487049 |
BXL628 |
BXL628 results in decreased expression of MEF2C mRNA | decreases expression | 16003237
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of MEF2C mRNA | affects expression | 17484886
|
D020111 |
Chlorodiphenyl (54% Chlorine) |
Chlorodiphenyl (54% Chlorine) results in increased expression of MEF2C mRNA | increases expression | 16934159
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of MEF2C mRNA | increases expression | 20106945
|
C014347 |
decitabine |
decitabine results in increased expression of MEF2C mRNA | increases expression | 19151715
|
C081021 |
Go 6976 |
Go 6976 inhibits the reaction [Phenylephrine results in increased activity of MEF2C protein] | decreases reaction|increases activity | 19124542
|
C056599 |
icariin |
icariin affects the localization of MEF2C protein | affects localization | 18423597
|
C056599 |
icariin |
icariin results in increased expression of MEF2C mRNA | increases expression | 18423597
|
C056599 |
icariin |
SB 203580 inhibits the reaction [icariin affects the localization of MEF2C protein] | affects localization|decreases reaction | 18423597
|
C056599 |
icariin |
SB 203580 inhibits the reaction [icariin results in increased expression of MEF2C mRNA] | decreases reaction|increases expression | 18423597
|
C056599 |
icariin |
U 0126 inhibits the reaction [icariin affects the localization of MEF2C protein] | affects localization|decreases reaction | 18423597
|
C056599 |
icariin |
U 0126 inhibits the reaction [icariin results in increased expression of MEF2C mRNA] | decreases reaction|increases expression | 18423597
|
C063302 |
KN 62 |
KN 62 inhibits the reaction [Phenylephrine results in increased expression of MEF2C mRNA] | decreases reaction|increases expression | 10737771
|
D018817 |
N-Methyl-3,4-methylenedioxyamphetamine |
N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of MEF2C mRNA | increases expression | 19285098
|
C008493 |
methylselenic acid |
methylselenic acid results in increased expression of MEF2C mRNA | increases expression | 18548127
|
D009151 |
Mustard Gas |
Mustard Gas results in increased expression of MEF2C mRNA | increases expression | 15674843
|
C007350 |
nitrofen |
nitrofen results in decreased expression of MEF2C mRNA | decreases expression | 18280291
|
D010656 |
Phenylephrine |
Go 6976 inhibits the reaction [Phenylephrine results in increased activity of MEF2C protein] | decreases reaction|increases activity | 19124542
|
D010656 |
Phenylephrine |
Phenylephrine results in increased activity of MEF2C protein | increases activity | 19124542
|
D010656 |
Phenylephrine |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Phenylephrine results in increased expression of MEF2C mRNA] | decreases reaction|increases expression | 10737771
|
D010656 |
Phenylephrine |
KN 62 inhibits the reaction [Phenylephrine results in increased expression of MEF2C mRNA] | decreases reaction|increases expression | 10737771
|
D010656 |
Phenylephrine |
Phenylephrine results in increased expression of MEF2C mRNA | increases expression | 10737771
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of MEF2C mRNA | decreases expression | 18445702
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of MEF2C mRNA | increases expression | 17951219
|
C059514 |
resveratrol |
resveratrol results in increased expression of MEF2C mRNA | increases expression | 12002526
|
C116926 |
rofecoxib |
rofecoxib affects the expression of MEF2C mRNA | affects expression | 17070997
|
C093642 |
SB 203580 |
SB 203580 inhibits the reaction [icariin affects the localization of MEF2C protein] | affects localization|decreases reaction | 18423597
|
C093642 |
SB 203580 |
SB 203580 inhibits the reaction [icariin results in increased expression of MEF2C mRNA] | decreases reaction|increases expression | 18423597
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of MEF2C mRNA | decreases expression | 19465110
|
C113580 |
U 0126 |
U 0126 inhibits the reaction [icariin affects the localization of MEF2C protein] | affects localization|decreases reaction | 18423597
|
C113580 |
U 0126 |
U 0126 inhibits the reaction [icariin results in increased expression of MEF2C mRNA] | decreases reaction|increases expression | 18423597
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of MEF2C mRNA | increases expression | 19101580
|
C025643 |
vinclozolin |
vinclozolin affects the expression of MEF2C mRNA | affects expression | 19015723
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.49 | 14514962 11752688 15322242 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
7.49 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.71 | 19490988 |
MESH:D000168 |
Acrocephalosyndactylia |
|
U 0126 |
5.23 | 17694057 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.63 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.89 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
1.93 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
10.37 | 3712494 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
10.37 | 6695378 |
MESH:D000236 |
Adenoma |
|
resveratrol |
10.37 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
9.08 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.08 | 16835633 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
4.96 | 17306315 |
MESH:D000544 |
Alzheimer Disease |
|
icariin |
4.67 | 19782061 19858766 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
4.67 | 16183991 16162502 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
4.98 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.73 | 11748828 |
MESH:D000855 |
Anorexia |
|
N-Methyl-3,4-methylenedioxyamphetamine |
5.11 | 15146954 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
8.21 | 17497229 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
8.21 | 19015723 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.83 | 19183758 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Amiodarone |
8.44 | 18218290 18057881 20041841 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
8.44 | 17460149 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.80 | 16251483 12569548 16835338 18414634 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
7.48 | 17115116 |
MESH:D001169 |
Arthritis, Experimental |
|
rofecoxib |
7.48 | 16690336 |
MESH:D001249 |
Asthma |
|
Mustard Gas |
2.64 | 10378619 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
6.41 | 19371607 12928151 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
6.41 | 17967414 16873680 |
MESH:D001281 |
Atrial Fibrillation |
|
Amiodarone |
3.72 | 18651412 19698954 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.03 | 17688650 19460635 17157402 20603192 18940202 18558336 18775368 15238991 18396377 18985861 16609825 19232924 18177632 17507914 18316065 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.77 | 1440618 11289319 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
2.95 | 20046352 17594078 |
MESH:D001768 |
Blister |
|
Mustard Gas |
4.91 | 19167455 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Amiodarone |
14.03 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
14.03 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
14.03 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.54 | 15340226 |
MESH:D001847 |
Bone Diseases |
|
icariin |
6.16 | 18295595 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.50 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.50 | 8888407 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.64 | 11985600 |
MESH:D001919 |
Bradycardia |
|
Phenylephrine |
4.30 | 15306635 |
MESH:D002545 |
Brain Ischemia |
|
icariin |
9.92 | 19303870 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
9.92 | 17600658 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.26 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
2.26 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.26 | 18320071 19208741 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
2.26 | 16393696 17651959 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.26 | 20435547 |
MESH:D001989 |
Bronchiolitis Obliterans |
|
Mustard Gas |
4.91 | 15286001 |
MESH:D029481 |
Bronchitis, Chronic |
|
Mustard Gas |
4.73 | 10378619 17687719 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.54 | 15673190 18705752 15700767 16011737 16227642 10355542 15721981 16192424 16097048 16124888 3786805 16050911 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.61 | 16835633 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.45 | 17687452 15504454 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
6.27 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
6.27 | 16507464 17306315 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
6.27 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
6.27 | 19321006 16227395 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.74 | 17123778 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.35 | 16675471 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.56 | 7296757 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
10.22 | 17687452 15504454 18922899 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
10.22 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
10.22 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
10.22 | 16227395 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
3.86 | 18640142 |
MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
6.43 | 11754973 15728586 16170337 17124262 17287366 11179087 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.43 | 18850075 18670907 16120746 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Amiodarone |
2.81 | 15710769 19225199 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
7.01 | 15738583 17938729 19152805 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
7.01 | 15458977 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
4.10 | 16973168 18022660 |
MESH:D002341 |
Carotid Artery Thrombosis |
|
Amiodarone |
4.84 | 18974383 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
6.02 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.02 | 12371664 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.62 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.96 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
12.34 | 19486331 9022650 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
12.34 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
12.34 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.00 | 16354765 8697196 12621046 15340226 15668235 |
MESH:D003092 |
Colitis |
|
resveratrol |
3.89 | 16474422 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
5.76 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
5.76 | 16338953 |
MESH:D003110 |
Colonic Neoplasms |
|
rofecoxib |
5.76 | 12902858 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.66 | 18981723 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
2.66 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.85 | 17141729 14669216 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.60 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
nitrofen |
3.78 | 11405365 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.78 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
3.78 | 8888407 17688650 16575769 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.11 | 14966744 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.57 | 11906362 8156756 8970840 18759878 2524372 12868966 14531868 11298694 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.31 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.26 | 3621924 2952479 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.57 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.61 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
3.76 | 16286809 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
14.28 | 18289764 9653073 18692083 6679447 9022650 8291058 11289319 1440618 6482804 18648102 16192314 7440962 9328219 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Amiodarone |
14.28 | 18218290 15265979 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
14.28 | 16227642 15998439 21278145 7179309 17522070 10915739 7440962 15027814 4309450 3732212 2869522 6884620 19336974 3786805 16177239 7120509 9327722 10092053 19085960 6623471 11566570 15968718 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Chlorodiphenyl (54% Chlorine) |
14.28 | 17851650 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
14.28 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
14.28 | 1733752 19641884 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.58 | 11462148 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.82 | 1851702 |
MESH:D004487 |
Edema |
|
Mustard Gas |
14.64 | 11428631 11428647 11402378 9260866 |
MESH:D004487 |
Edema |
|
pirinixic acid |
14.64 | 12083418 |
MESH:D004487 |
Edema |
|
resveratrol |
14.64 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
14.64 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.65 | 15322242 16714409 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
3.79 | 17872969 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
4.87 | 19294695 |
MESH:D004715 |
Endometriosis |
|
rofecoxib |
8.62 | 15652904 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
8.62 | 9294722 10568697 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.61 | 17923197 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
3.91 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.67 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.81 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.38 | 7562514 6426943 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.06 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
3.82 | 3659116 |
MESH:D007172 |
Erectile Dysfunction |
|
icariin |
5.20 | 16281085 15329286 |
MESH:D004890 |
Erythema |
|
Mustard Gas |
4.91 | 9357497 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
4.14 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.14 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.83 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Amiodarone |
22.30 | 14986274 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
22.30 | 16239168 15959796 19224547 12631006 61145 12795759 16045604 17595544 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
22.30 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
22.30 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
22.30 | 19224547 14986274 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.21 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.64 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
3.90 | 8888407 18558336 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.77 | 6705139 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
13.31 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
13.31 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
13.31 | 20067830 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
5.31 | 6392382 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
4.69 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.05 | 16417039 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.97 | 8708960 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.81 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.34 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.32 | 19215824 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
10.52 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
nitrofen |
10.52 | 16080930 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
10.52 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.39 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.17 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.12 | 11000095 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
8.44 | 6705139 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
8.44 | 19900420 19110552 |
MESH:D006529 |
Hepatomegaly |
|
Amiodarone |
13.02 | 15265979 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
13.02 | 19176532 16221962 19772884 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
13.02 | 15340226 12621046 16120746 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
nitrofen |
3.85 | 10541330 15764645 16863852 12407540 16080930 10359170 11588001 15756563 17270546 7760232 18280291 17245593 9476886 10898224 16473863 15578192 7576705 10693666 12547725 8863223 16720372 12194112 10646786 10370016 10898222 12759764 12746050 11076806 16292651 15136996 15707848 11409163 11685700 12505043 9575882 11584395 10370017 9698600 17618886 15088113 11051153 9859898 18958481 7520565 15185205 12021965 9473106 12904592 11057544 15793718 16490937 11329586 18280292 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.94 | 16876885 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.62 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.80 | 8697196 16959395 15340226 16354765 18606429 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.28 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
|
Amiodarone |
8.59 | 8137927 9751232 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
8.59 | 17188708 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.97 | 20558911 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.24 | 17050553 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
3.80 | 16873680 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.70 | 15034207 |
MESH:D006973 |
Hypertension |
|
Arsenic |
11.61 | 16076760 11953799 9931084 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
11.61 | 10903974 |
MESH:D006973 |
Hypertension |
|
Phenylephrine |
11.61 | 12717712 8949925 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
11.61 | 18670907 18850075 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.85 | 15338365 |
MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
4.33 | 18502941 12791704 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.09 | 17488730 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
5.31 | 16093927 |
MESH:D007037 |
Hypothyroidism |
|
Amiodarone |
4.27 | 18020914 17991464 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.40 | 17600658 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
6.39 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
6.39 | 16467254 |
MESH:D007249 |
Inflammation |
|
Mustard Gas |
7.65 | 16001271 11428620 17524151 8975870 9357497 11428631 11428647 9260866 11402378 |
MESH:D007249 |
Inflammation |
|
resveratrol |
7.65 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
7.65 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.30 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
6.79 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
6.79 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
rofecoxib |
4.79 | 15831440 |
MESH:D007417 |
Intestinal Polyps |
|
rofecoxib |
5.14 | 11245490 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.77 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.12 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.19 | 15604871 |
MESH:D007642 |
Keratosis |
|
Arsenic |
4.74 | 12749816 16930632 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.20 | 18776723 10903974 8314463 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
6.61 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
6.61 | 12371664 |
MESH:D007859 |
Learning Disorders |
|
icariin |
5.08 | 19782061 |
MESH:D007938 |
Leukemia |
|
decitabine |
2.95 | 18980019 19235587 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
U 0126 |
5.06 | 16972261 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
3.78 | 18454857 19117987 17236224 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
3.84 | 19387464 18460780 18704418 19010910 17679729 18206229 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
3.84 | 17596541 16294345 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.21 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
7.39 | 17339181 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
7.39 | 16087638 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.48 | 16417039 |
MESH:D008064 |
Lipidoses |
|
Amiodarone |
3.34 | 15342952 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
2.67 | 21278145 17157831 11408273 17174718 16239168 17334410 16221502 11903743 16943688 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.04 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
4.73 | 15650968 12445418 17721639 15338365 15893842 18277467 15996030 18472094 12958196 18006644 14724832 17708605 12667390 18472332 18263696 17698563 15876570 18420326 15959796 12609069 10355542 18376398 12632514 18054572 12586293 18210741 12445421 17823541 18205269 12389079 18429990 15370692 11481614 18251166 16011737 14716833 20821823 15818738 15123356 14716496 18317297 12666154 15052691 18395095 17640975 18395914 17766677 15673190 16116963 15730626 12546737 17761835 18156304 17481882 17976157 16015684 17557913 16033810 15362042 16097048 12898905 17900296 18339082 16638106 18187930 14620537 17565644 18412020 17525996 15925388 13678700 14748882 12632512 16136751 16192424 17714472 18418968 12649538 17631135 14512876 18279442 17805973 12741479 17869086 16027843 15931870 18705752 17922224 18481824 16248980 18166357 15057751 17944888 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
4.73 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
rofecoxib |
4.73 | 17565644 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.73 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
4.02 | 11134558 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
4.02 | 17285989 16246199 16964402 15830285 15720792 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.92 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.48 | 14706259 16899240 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
16.75 | 16368122 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
16.75 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
16.75 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
16.75 | 16377806 15890375 20007298 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
16.75 | 20405173 19812893 19321006 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
16.75 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
8.90 | 1399818 598648 3712494 6587162 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
8.90 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
8.90 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
Amiodarone |
3.39 | 11989578 15350150 17391786 |
MESH:D008171 |
Lung Diseases |
|
Amiodarone |
11.63 | 12587719 |
MESH:D008171 |
Lung Diseases |
|
Mustard Gas |
11.63 | 18702808 18161513 |
MESH:D008171 |
Lung Diseases |
|
nitrofen |
11.63 | 16863852 9614859 9859898 17245593 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Amiodarone |
10.43 | 18516814 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
10.43 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
4.61 | 17976673 19168569 17306315 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
4.61 | 20869020 20464547 18520028 18569708 17053015 18816296 20064080 20135361 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Mustard Gas |
4.61 | 3148597 8781369 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.61 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.25 | 19470736 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
4.07 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.67 | 14749477 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
4.00 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
2.96 | 11606380 8985016 |
MESH:D008545 |
Melanoma |
|
decitabine |
3.43 | 16505122 17785578 |
MESH:D008545 |
Melanoma |
|
resveratrol |
3.43 | 17992120 |
MESH:D008569 |
Memory Disorders |
|
icariin |
5.06 | 19782061 |
OMIM:613443 |
MENTAL RETARDATION, STEREOTYPIC MOVEMENTS, EPILEPSY, AND/OR CEREBRAL MALFORMATIONS |
marker/mechanism |
|
| |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.16 | 17112576 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.54 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.02 | 18803445 18765137 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.00 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
6.94 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
6.94 | 17164350 16490592 16267019 17049120 14749477 17935668 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.62 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.27 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.81 | 8888407 |
MESH:D009181 |
Mycoses |
|
Amiodarone |
4.65 | 12754197 17974566 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
7.04 | 16882708 19010910 18608210 19157545 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
7.04 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.40 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
5.40 | 17188708 16317513 16525036 16456233 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
14.19 | 15371236 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
14.19 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
14.19 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.76 | 16411023 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.51 | 17322642 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
2.37 | 3581430 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
7.52 | 11141357 |
MESH:D009369 |
Neoplasms |
|
decitabine |
7.52 | 19470736 19116145 17925555 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
7.52 | 17405874 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
3.76 | 8985016 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.19 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.08 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
8.80 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
8.80 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
11.26 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
11.26 | 16620997 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
11.26 | 8888407 16359493 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
3.61 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
9.94 | 17056641 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
9.94 | 17929310 |
MESH:D009503 |
Neutropenia |
|
Mustard Gas |
3.74 | 16761898 7688884 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.75 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
3.21 | 6482804 4026338 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.77 | 3988306 |
MESH:D010003 |
Osteoarthritis |
|
rofecoxib |
4.23 | 16690336 |
MESH:D010024 |
Osteoporosis |
|
icariin |
4.46 | 18236786 19747809 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
4.03 | 17513867 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.74 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
7.65 | 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
7.65 | 19259094 19331143 |
MESH:D010051 |
Ovarian Neoplasms |
|
U 0126 |
7.65 | 16211241 |
MESH:D010149 |
Pain, Postoperative |
|
rofecoxib |
5.14 | 16678543 18165598 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
2.68 | 19294695 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.24 | 7296757 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.00 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
3.94 | 16093927 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
4.74 | 16905509 15371236 6392382 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.22 | 6228378 |
MESH:D011041 |
Poisoning |
|
Mustard Gas |
3.57 | 15727166 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.32 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.02 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
27.82 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
27.82 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
27.82 | 11896295 11118676 11222880 11399792 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
27.82 | 20603192 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
27.82 | 18220299 18042343 19015723 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.49 | 17616702 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
4.69 | 18220299 |
MESH:D011470 |
Prostatic Hyperplasia |
|
BXL628 |
6.27 | 16957418 15572423 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
3.99 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
1.90 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
1.90 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
1.90 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
methylselenic acid |
1.90 | 16205645 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
1.90 | 17636462 16731767 17675339 17718901 17804756 15767336 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
4.69 | 18629315 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
3.78 | 21343184 |
MESH:D011537 |
Pruritus |
|
Mustard Gas |
3.85 | 18058305 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.29 | 11422049 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.14 | 16882103 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.54 | 10548101 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Amiodarone |
5.53 | 12490602 11597910 12832656 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Mustard Gas |
5.53 | 10334151 17266442 17894541 17720292 17620002 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.33 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
6.17 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
6.17 | 15827377 16314181 17520802 16317513 17058453 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.60 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.19 | 3692021 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
10.22 | 19155313 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
10.22 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.04 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.58 | 1511512 11738929 3137016 15475178 14763951 16876388 11044598 17978042 |
OMIM:609620 |
SHORT QT SYNDROME 1 |
|
Amiodarone |
4.84 | 18724381 |
MESH:D012852 |
Sinusitis |
|
Phenylephrine |
4.46 | 7327846 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
4.92 | 18709164 19834688 16759981 15952646 17938729 16702368 6392382 17548696 16353154 17050553 17453740 |
MESH:D012871 |
Skin Diseases |
|
Mustard Gas |
4.92 | 15451306 12880345 16961503 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
12.63 | 19538983 17976673 15504454 17029826 16251483 17050553 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
12.63 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
12.63 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
12.63 | 16192470 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.59 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.29 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.39 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.39 | 19037991 |
MESH:D013276 |
Stomach Ulcer |
|
Amiodarone |
3.10 | 18087811 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.27 | 16321402 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.74 | 16684133 16045194 |
MESH:D013610 |
Tachycardia |
|
Amiodarone |
4.05 | 11238279 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Amiodarone |
3.95 | 19225199 |
MESH:D013959 |
Thyroid Diseases |
|
Amiodarone |
11.22 | 19731979 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
11.22 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
6.63 | 1399818 6582329 6587162 7505956 3712494 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
6.63 | 17967635 |
MESH:D013971 |
Thyrotoxicosis |
|
Amiodarone |
4.62 | 19584973 18020914 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
4.00 | 16227395 |
MESH:D016171 |
Torsades de Pointes |
|
Amiodarone |
3.94 | 11989578 17467628 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
4.98 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.27 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
11.14 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
11.14 | 19322015 17306315 11144890 15987713 17976673 18640142 19429237 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
11.14 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
11.14 | 19087683 17616700 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.40 | 8888407 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
3.89 | 17473185 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.76 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
3.90 | 17044934 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
4.66 | 17785578 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.73 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
4.49 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.34 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
4.06 | 17488730 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.00 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.19 | 17120751 |